Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 51.31% | -59.25% | -37.90% | -16.06% | -84.38% |
| Total Depreciation and Amortization | -14.29% | 11.18% | 10.27% | 4.91% | -0.53% |
| Total Amortization of Deferred Charges | 88.95% | 113.65% | 75.44% | 47.96% | 31.68% |
| Total Other Non-Cash Items | -161.59% | 16.79% | 52.46% | 75.32% | 617.83% |
| Change in Net Operating Assets | 134.13% | -46.31% | -105.43% | -90.69% | -26.75% |
| Cash from Operations | -65.24% | -174.59% | -159.87% | -59.29% | -4.66% |
| Capital Expenditure | 100.00% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -160.53% | -160.53% | -150.61% | -46.77% | 74.26% |
| Cash from Investing | -264.47% | -223.73% | -136.71% | -107.58% | -85.83% |
| Total Debt Issued | 28.16% | 76.65% | 107.63% | 68.76% | 22.54% |
| Total Debt Repaid | 19.54% | 4.79% | -8.17% | -23.23% | -18.94% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 70.60% | 184.13% | 270.69% | 124.39% | 25.94% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -42.03% | -166.76% | -- | -- | -- |